clinical trials

Pharmaceutical regulatory compliance in the UK ensures the safety, efficacy, and quality of medicines for public use. This comprehensive overview explores the framework established by key regulatory bodies like the MHRA, the challenges of navigating post-Brexit regulatory changes, and the role of advanced technologies in streamlining compliance processes. It highlights the importance of adherence to Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and pharmacovigilance requirements while addressing the complexities of clinical trials, supply chain integrity, and international trade. This guide serves as a valuable resource for understanding the evolving landscape of pharmaceutical compliance in the UK.